Published in Tidsskr Nor Laegeforen on September 13, 2016
Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome. Arthritis Rheumatol (2014) 1.97
[Treatment of stroke--an interdisciplinary challenge]. Tidsskr Nor Laegeforen (2011) 1.92
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.66
Retracted [Optic neuritis--diagnosis, treatment and follow up]. Tidsskr Nor Laegeforen (2005) 1.43
[New diagnostic criteria in multiple sclerosis]. Tidsskr Nor Laegeforen (2003) 1.38
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway. Mult Scler (2012) 1.04
Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway. J Neurol (2007) 1.01
Gray matter correlations of cognition in incident Parkinson's disease. Mov Disord (2010) 1.01
Dementia in Parkinson's disease. Curr Opin Neurol (2008) 1.00
Brain atrophy and white matter hyperintensities in early Parkinson's disease(a). Mov Disord (2009) 0.98
Depressive symptoms account for deficient information processing speed but not for impaired working memory in early phase multiple sclerosis (MS). J Neurol Sci (2004) 0.93
25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler (2009) 0.92
Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway. J Neurol (2013) 0.92
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Mult Scler (2013) 0.91
Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment. Neurobiol Aging (2011) 0.89
Vitamin D in the healthy and inflamed central nervous system: access and function. J Neurol Sci (2011) 0.88
White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease. Neuroimage (2009) 0.87
Autism spectrum disorder, functional MRI and MR spectroscopy: possibilities and challenges. Microb Ecol Health Dis (2012) 0.85
Memory dysfunction in primary Sjögren's syndrome is associated with anti-NR2 antibodies. Arthritis Rheum (2013) 0.84
White matter hyperintensities and the course of depressive symptoms in elderly people with mild dementia. Dement Geriatr Cogn Dis Extra (2012) 0.84
Ventricular enlargement and mild cognitive impairment in early Parkinson's disease. Mov Disord (2010) 0.84
Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study. BMC Neurol (2014) 0.84
Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study. Am J Geriatr Psychiatry (2013) 0.83
Multispectral MRI segmentation of age related white matter changes using a cascade of support vector machines. J Neurol Sci (2012) 0.83
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study. PLoS One (2012) 0.82
(123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study. BMJ Open (2013) 0.82
Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. PLoS One (2013) 0.80
Mapping cortical atrophy in Parkinson's disease patients with dementia. J Parkinsons Dis (2013) 0.79
Perceptions of illness and its development in patients with multiple sclerosis: a prospective cohort study. J Adv Nurs (2008) 0.79
[Retraction of article]. Tidsskr Nor Laegeforen (2005) 0.78
Neuroimaging of cognitive impairments in vascular disease. Int Rev Neurobiol (2009) 0.77
Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies. Dement Geriatr Cogn Disord (2012) 0.77
Relationship between orthostatic hypotension and white matter hyperintensity load in older patients with mild dementia. PLoS One (2012) 0.77
Migraine is frequent in patients with systemic lupus erythematosus: a case-control study. Cephalalgia (2010) 0.76
Cost-effectiveness of natalizumab in multiple sclerosis. Expert Rev Pharmacoecon Outcomes Res (2008) 0.76
[New gene map for multiple sclerosis]. Tidsskr Nor Laegeforen (2011) 0.76
Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs. Mult Scler (2004) 0.75
[Treatment of multiple sclerosis]. Tidsskr Nor Laegeforen (2010) 0.75
Tidsskr Nor Laegeforen (2016) 0.75
Tidsskr Nor Laegeforen (2016) 0.75
[Incorrect information about treatment of multiple sclerosis from the Knowledge Center]. Tidsskr Nor Laegeforen (2007) 0.75
Tidsskr Nor Laegeforen (2017) 0.75
[Multiple sclerosis--a disease with complex genetics]. Tidsskr Nor Laegeforen (2003) 0.75
Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis. J Neuroimmunol (2003) 0.75
Primary uterine rhabdomyosarcoma in a patient with a history of breast cancer and gastrointestinal stromal tumor. J Obstet Gynaecol Res (2008) 0.75
[A rush job and knowledge handling]. Tidsskr Nor Laegeforen (2007) 0.75
[Development of new therapies for multiple sclerosis]. Tidsskr Nor Laegeforen (2011) 0.75
Primary osseous rhabdomyosarcoma with focal matrix formation mimicking osteosarcoma. Pathol Res Pract (2007) 0.75